|
LSM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.346400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.560000E-01 |
| Normal-vs-Stage2 |
6.191400E-01 |
| Normal-vs-Stage3 |
2.119600E-01 |
| Normal-vs-Stage4 |
2.790100E-02 |
| Stage1-vs-Stage2 |
5.019800E-01 |
| Stage1-vs-Stage3 |
1.100840E-01 |
| Stage1-vs-Stage4 |
9.116600E-03 |
| Stage2-vs-Stage3 |
6.476200E-01 |
| Stage2-vs-Stage4 |
2.093000E-01 |
| Stage3-vs-Stage4 |
3.333600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.734200E-01 |
| Normal-vs-AfricanAmerican |
1.928240E-01 |
| Normal-vs-Asian |
6.542400E-01 |
| Caucasian-vs-AfricanAmerican |
4.407200E-01 |
| Caucasian-vs-Asian |
2.544600E-01 |
| AfricanAmerican-vs-Asian |
1.324000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.612800E-01 |
| Normal-vs-Female |
5.301400E-01 |
| Male-vs-Female |
9.082400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.719200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.961800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.967240E-01 |
| Normal-vs-Age(81-100Yrs) |
2.109200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.739800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.769820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.024780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.083400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.487700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.789780E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.069200E-01 |
| Classical-VS-Follicular |
1.803980E-01 |
| Classical-VS-Other |
6.564800E-01 |
| Classical-VS-Normal |
4.714200E-01 |
| Tall-VS-Follicular |
8.347700E-02 |
| Tall-VS-Other |
4.075800E-01 |
| Tall-VS-Normal |
1.818390E-01 |
| Follicular-VS-Other |
9.307200E-01 |
| Follicular-VS-Normal |
4.912200E-01 |
| Other-VS-Normal |
8.764600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.606800E-01 |
| Normal-vs-N1 |
1.809800E-01 |
| N0-vs-N1 |
2.904200E-01 |
|
|
